Our Company DocGo is leading the proactive healthcare revolution. We are democratizing access with our innovative care delivery platform that includes mobile health services, virtual care management and ambulance services. Our goal is to deliver healthcare at any address and help reshape the traditional healthcare system, driven by our mission to bring high quality, highly accessible care to all. DocGo’s proprietary technology platform, dedicated network of certified health professionals and robust fleet of medical response vehicles provide services in 31 states and the United Kingdom. DocGo’s vertically integrated approach helps elevate the quality of patient care and drive business efficiencies for municipalities, hospital networks and health insurance providers.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 368M | 617M | 624M | 441M | 319M |
| Net Income | -53M | 20M | 6.9M | 35M | 24M |
| EPS | $-0.53 | $0.18 | $0.06 | $0.34 | $0.25 |
| Free Cash Flow | 54M | 67M | -72M | 26M | -6.8M |
| ROIC | -32.4% | 7.1% | 3.3% | 24.2% | 43.7% |
| Gross Margin | - | 34.6% | 31.3% | 35.1% | 34.4% |
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Dividends/Share | $0.00 | - | - | - | - |
| Operating Income | -81M | 29M | 15M | 22M | 15M |
| Operating Margin | -22.0% | 4.7% | 2.4% | 5.0% | 4.8% |
| ROE | -19.5% | 6.4% | 2.3% | 12.7% | 17.3% |
| Shares Outstanding | 98M | 111M | 114M | 102M | 95M |
| Metric | 2021 | 2022 | |||
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 319M | 441M | 624M | 617M | 368M |
| Gross Margin | 34.4% | 35.1% | 31.3% | 34.6% | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A |
| EBIT | 15M | 22M | 15M | 29M | -81M |
| Op. Margin | 4.8% | 5.0% | 2.4% | 4.7% | -22.0% |
| Net Income | 24M | 35M | 6.9M | 20M | -53M |
| Net Margin | 7.4% | 7.9% | 1.1% | 3.2% | -14.3% |
| Non-Recurring | -34K | 2.9M | -853K | 24K | 24K |
| Returns on Capital | |||||
| ROIC | 43.7% | 24.2% | 3.3% | 7.1% | -32.4% |
| ROE | 17.3% | 12.7% | 2.3% | 6.4% | -19.5% |
| ROA | 11.6% | 8.8% | 1.4% | 4.2% | -14.9% |
| Cash Flow | |||||
| Op. Cash Flow | -1.9M | 29M | -64M | 70M | 58M |
| Free Cash Flow | -6.8M | 26M | -72M | 67M | 54M |
| Owner Earnings | -5.6M | 17M | -90M | 51M | 39M |
| CapEx | 4.8M | 3.2M | 7.6M | 3.8M | 3.9M |
| Maint. CapEx | 2.3M | 4.1M | 4.8M | 5.6M | 5.6M |
| Growth CapEx | 2.5M | 0 | 2.8M | 0 | 0 |
| D&A | 2.3M | 4.1M | 4.8M | 5.6M | 5.6M |
| CapEx/OCF | N/A | 11.1% | N/A | 5.5% | 6.8% |
| Capital Allocation | |||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 3.7M | 0 | 14M | 14M |
| Buyback Yield | N/A | 0.6% | N/A | 2.8% | 26.1% |
| Stock-Based Comp | 1.4M | 8.1M | 21M | 14M | 14M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||
| Net Debt | -174M | -156M | -59M | -89M | -73M |
| Cash & Equiv. | N/A | N/A | N/A | N/A | 73M |
| Long-Term Debt | 1.3M | 1.2M | 42K | 5K | 5K |
| Debt/Equity | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | 107.6 | N/A | 8.9 | 14.9 | 14.9 |
| Equity | 220M | 273M | 301M | 321M | 271M |
| Total Assets | 310M | 393M | 490M | 456M | 354M |
| Total Liabilities | 83M | 114M | 185M | 140M | 93M |
| Intangibles | 19M | 62M | 85M | 73M | 73M |
| Retained Earnings | -64M | -29M | -21M | -1.4M | -1.4M |
| Working Capital | 198M | 171M | 169M | 183M | 183M |
| Current Assets | 256M | 271M | 339M | 304M | 304M |
| Current Liabilities | 58M | 100M | 170M | 122M | 122M |
| Per Share Data | |||||
| EPS | 0.25 | 0.34 | 0.06 | 0.18 | -0.53 |
| Owner EPS | -0.06 | 0.16 | -0.79 | 0.46 | 0.39 |
| Book Value | 2.31 | 2.69 | 2.63 | 2.89 | 2.77 |
| Cash Flow/Share | -0.02 | 0.28 | -0.56 | 0.63 | -0.48 |
| Dividends/Share | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 95.0M | 101.7M | 114.3M | 111.1M | 97.8M |
| Valuation | |||||
| P/E Ratio | 37.5 | 19.1 | 93.5 | 24.3 | -1.0 |
| P/FCF | N/A | 25.8 | N/A | 7.3 | 1.0 |
| EV/EBIT | 46.7 | 23.2 | 38.7 | 13.8 | N/A |
| Price/Book | 4.1 | 2.4 | 2.1 | 1.5 | 0.2 |
| Price/Sales | 2.9 | 1.9 | 1.4 | 0.6 | 0.1 |
| FCF Yield | -0.8% | 3.9% | -11.2% | 13.7% | 102.2% |
| Market Cap | 891M | 662M | 641M | 486M | 53M |
| Avg. Price | 9.86 | 8.10 | 7.85 | 3.58 | 0.54 |
| Year-End Price | 9.38 | 6.51 | 5.61 | 4.38 | 0.54 |
DocGo Inc. passes 3 of 9 quality checks, indicating weak fundamentals.
On a free-cash-flow basis, the stock trades at 1.0x vs a median of 16.6x. The company's 5-year average ROIC is 19.6% with a gross margin of 33.9%. Total shareholder yield (buybacks) is 26.1%. At current prices, the estimated annualized return to fair value is +59.3%.
DocGo Inc. (DCGO) has a 5-year average return on invested capital (ROIC) of 19.6%. This indicates strong capital allocation and a potential competitive advantage.
DocGo Inc. (DCGO) has a market capitalization of $53M. It is classified as a small-cap stock.
DocGo Inc. (DCGO) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 26.11%.
DocGo Inc. (DCGO) operates in the Services-Health Services industry, within the Healthcare sector.
DocGo Inc. (DCGO) reported annual revenue of $617 million in its most recent fiscal year, based on SEC EDGAR filings.
DocGo Inc. (DCGO) has a net profit margin of 3.2%. This is a modest margin.
DocGo Inc. (DCGO) generated $67 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
DocGo Inc. (DCGO) has a debt-to-equity ratio of 0.00. This indicates a conservatively financed balance sheet.
DocGo Inc. (DCGO) reported earnings per share (EPS) of $0.18 in its most recent fiscal year.
DocGo Inc. (DCGO) has a return on equity (ROE) of 6.4%. This indicates moderate shareholder returns.
DocGo Inc. (DCGO) has a 5-year average gross margin of 33.9%. This indicates decent pricing power.
The Ledger Terminal provides 4 years of financial data for DocGo Inc. (DCGO), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
DocGo Inc. (DCGO) has a book value per share of $2.89, based on its most recent annual SEC filing.